“…Data in the present study, however, suggest that monomers lack enzymatic activity, reinforcing the speculation that if a peptide inhibitor were designed to compete with dimer interface sequences, and thereby prevent dimerization, then it might be possible to abate FAP activity in pathologic conditions such as certain neoplasms. 23,37,38 Although our data support that APCE is soluble FAP and that its homodimeric structure appears to be required for activity expression, we also explored whether the enzymes shared substrate specificities. The synthetic substrates, Ala-Pro-AFC and Z-Gly-Pro-AMC, and the FRET peptide, synthesized to contain P4-P4Ј residues of Met-␣ 2 AP (Table 1), were used for kinetic assessments.…”